Speaker Details


Bret Jensen is the lead analyst for small-cap and large-cap stocks at Investors Alley. He was recently ranked in the top 1% of contributors with Seeking Alpha and is also regular contributor to TheStreet.com's Real Money and TalkMarkets, in addition to his primary duties with Investors Alley. Formerly, Mr. Jensen was a technology director for American Express for over two decades before becoming chief investment strategist and co-founder of Simplified Asset Management, a specialty long/short hedge fund, which was ranked in the top 5% for total return during its first year. He is now the editor of Biotech Gems.

Content from Bret Jensen

Keyword Image
Invitae: Growth in Genetic Testing

Genetic testing is expected to grow from a current $3-$4 billion market to $8-$10 billion over the next 5-6 years, asserts biotechnology sector specialist says Bret Jensen, editor of Biotech Gems. …

Keyword Image
Adamas Targets Parkinson's and MS

Adamas Pharmaceuticals (ADMS) is a drug improvement company that develops chrono-synchronous therapies for patients affected by chronic neurological disorders, explains Bret Jensen, editor of Invest…

Keyword Image
Top Picks 2017: Celgene

My Top Pick among large cap stocks is a firm that should be known to just about every biotech investor; I can think of no other large cap biotech that has a clearer earnings growth trajectory over …

Keyword Image
Top Picks 2017: Aratana Therapeutics

With a market capitalization of approximately $300 million, our Top Pick among small caps is an under the radar biotech idea, explains Bret Jensen, editor of Investor Alley's Biotech Gems. Aratana…

Keyword Image
Two Techs with Cash Abroad

There is an estimated $2.5 trillion in stranded corporation cash overseas is brought back home; this could change based on our newly-elected President's promises, says Bret Jensen, editor of The Gr…

Keyword Image
Baker Brothers & Biotech Bets

In the world of biotechnology and healthcare, the billionaire duo of Julian and Felix Baker – the Baker Brothers – have earned their reputation, states Bret Jensen, editor of Biotech Gem…

Keyword Image
Homebuilding Buy: Insiders Bet on Beazer

With home ownership at the lowest levels since 1965 in this country, we have nowhere to go but up as long as economic growth continues to muddle forward, asserts Bret Jensen, editor of Investing All…

Keyword Image
Lennar: Building Returns in a Hot Sector

To gain exposure to the hot housing sector, we are looking at one well-run and well-positioned home builder, states Bret Jensen, editor of Blue Chip Gems. With a $10 billion market capitalization,…